Research note: Drug consumption rooms and needle and syringe exchange programs

Journal of Drug Issues

Volumn 37, Issue 3, 2007, Pages 737-748

  Patel, Kiran ^a  

^a SPRINGFIELD UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35248875712     PISSN: 00220426     EISSN: None     Source Type: Journal    
DOI: 10.1177/002204260703700312     Document Type: Article

References (44)

1. Bastos, F. I., & Strathdee, S. A. 2000 Evaluating effectiveness of syringe exchange programs: Current issues and future prospects. Social Science and Medicine, 51(12), 1771-1782.
2. Braine, N., Des Jarlais, D., & Goldblatt, C. 2004 Long-term effects of syringe exchange on risk behavior and HIV prevention. AIDS Education and Prevention, 16(3), 264-275.
3. Bruneau, J., Lamothe, F., & Franco, E. 1997 High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study. American Journal of Epidemiology, 146(12), 994-1002.
4. Carlson, R. G. 2000 Shooting galleries, dope houses, and injection doctors: Examining the social ecology of HIV risk behaviors among drug injectors in Dayton, Ohio. Human Organ, 59(3), 325.
5. Centers for Disease Control and Prevention 2005 Basic statistics: AIDS cases by exposure category. Atlanta, GA: CDC.
6. Centers for Disease Control and Prevention 2002 Drug-associated HIV transmission continues in the United States. Atlanta, GA: CDC.
7. City of Vancouver Four Pillars Drug Strategy 2003 Supervised injection sites (SISs): Frequently asked questions. City of Vancouver.
8. De Jong, W., & Weber, U. 1999 The professional acceptance of drug use: A closer look at drug consumption rooms in the Netherlands, Germany and Switzerland. International Journal of Drug Policy, 10, 99-108.
9. Delgado, C. 2004 Evaluation of needle exchange programmes. Public Health Nursing, 21(20), 171-178.
10. Des Jarlais, D., Hagan, H., Friedman, S., Friedmann, P., Goldberg, P., Frischer, M., Green, S., Tunving, K., Ljungberg, B., & Wodak, A. 1995 Maintaining low HIV seroprevalence in populations of injecting drug users. Journal of the American Medical Association, 274, 1226-1231.
11. Drug Policy Alliance 1996 Integrative Drogenhilfe. Frankfurt: Drug Policy Alliance.
12. Drug Policy Alliance 1997 Integrative Drogenhilfe. Frankfurt: Drug Policy Alliance.
13. European Monitoring Centre for Drugs and Drug Addiction 2005 Annual report 2005: The state of the drugs problem in Europe. Lisbon: EMCDDA.
14. Glantz, L. H., & Mariner, W. K. 1996 Needle exchange programs and the law-time for a change. American Journal of Public Health, 86, 1077-78.
15. Gold, M., & Gafni, A. 1997 Needle exchange programs: An economic evaluation of a local experience. Canadian Medical Association Journal, 157(3), 255-262.
16. Goldstein, A. 1998 Clinton supports needle exchanges but not funding. Washington Post (April 21).
17. Guydish, J., & Bucardo, J. 1998 Evaluating needle exchange: A description of client characteristics, health status, program utilization and HIV risk behavior. Substance Use and Misuse, 33(5), 1173-1196.
18. Hedrich, D. 2004 European report on drug consumption rooms. Lisbon: EMCDDA.
19. Her Majesty's Stationery Office 2002 The government's drugs policy: Is it working? Home Affairs Committee Third Report. London, UK: HMSO
20. Holtgrave, D. R., & Pinkerton, S. D. 1997 Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. Journal of AIDS and Human Retrovirology, 16, 54-62.
21. Hurley, S., Jolley, D., & Kaldor, J. 1997 Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet, 349, 1797-1800.
22. Jacob, J. 1999 Entstehung und Praxis eines Gesundheitsraumangebotes für Drogenkonsmierende. Abschlußbericht der einjährigen Evaluation des 'drop-in Fixpunkt.' Hannover, Oldenburg.
23. Kelley, M., Murphy, S., & Lune, H. 2001 A cultural impact of needle exchange: The role of safer-injection mentors. Contemporary Drug Problems, 28, 485-505.
24. Ksobiech, K. 2003 A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Education and Prevention, 15(3), 257-268.
25. Laufer, F. 2001 Cost-effectiveness of syringe exchange as an HIV prevention strategy. Journal of AIDS, 28(3), 273-8.
26. Lazzarini, Z. 2001 An analysis of ethical issues in prescribing and dispensing syringes to injection drug users. Health Matrix Cleveland, 11(1), 85-128.
27. Lurie, P., & Drucker, E. 1997 An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet, 349, 604-608.
28. Lurie, P., & Reingold, A. 1993 The public health impact of needle exchange programs in the United States and abroad. Prepared for the Centers for Disease Control and Prevention.
29. Mansson, A. 2000 Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program. Scandinavian Journal of Infectious Diseases, 32(3), 253-258.
30. MacPherson, D. 1999 Comprehensive systems of care for drug users in Switzerland and Frankfurt, Germany: Report from the 10th International Conference on the Reduction of Drug Related Harm and a tour of harm reduction services in Frankfurt, Germany. Vancouver, Canada: City of Vancouver, Social Planning Department.
31. Medically Supervised Injecting Centre (MSIC) Evaluation Committee 2003 Final report on the evaluation report of the Sydney medically supervised centre. Sydney: MSIC Evaluation Committee.
32. Her Majesty's Stationery Office 1998 National Drug Strategy. London, UK: HMSO
33. Poschadel, S., Höger, J., Schnitzler, J., & Schreckenberg, D. 2003 Evaluation der arbeit der Drogenkonsumraume in der Bundesrepublik Deutschland: Endbericht im Auftrag des Bundesministeriums für Gesundheit. Das Bundesministerium fur Gesundheit und Soziale Sicherung. Baden-Baden: Nomos-Verlags-Gesellschaft.
34. Randerson, J. 2006 A mountain of anomalies. The Guardian (April 24).
35. Runcimen, R. 2006 The report of the independent working group on drug consumption rooms. Joseph Rowntree Foundation
36. Stoever, H. 2002 Consumption rooms - A middle ground between health and public order concerns. Journal of Drug Issues, 32, 597-606.
37. Strang, J., & Fortson, R. 2004 Supervised fixing rooms, supervised injectable maintenance clinics - Understanding the difference. British Medical Journal, 328(7431), 102-103.
38. Strathdee, S. A. 2004 The experts speak: Needle exchange programs and the prevention of HIV infection. AIDS Patient Care and Standards, 18(7), 373-378.
39. Strathdee, S. A. 1997 Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS, 11(8), 59-65.
40. Morbidity and Mortality Weekly Report 2005 Update: Syringe exchange programs - United States. Morbidity and Mortality Weekly Report, 54(27), 673-676.
41. Van Beek, I. 2003 The Sydney medically supervised injecting centre: A clinical model. Journal of Drug Issues, 22, 625-38.
42. Villarreal, H. & Fogg, C. 2006 Syringe exchange programs and HIV prevention: If they're effective, what's the controversy ? American Journal of Nursing, 106(5), 58-63.
43. Watters, J., Estilo, M., Clark, G., & Lorvick, J. 1994 Syringe and needle exchange as HIV/AIDS prevention for injection drug users. Journal of the American Medical Association, 271, 115-120.
44. Wright, N. M. J. 2004 Supervised injecting centres. British Medical Journal, 328(7431), 100-102.